A comparison of the in vitro effects of three fibrinogen concentrates on clot strength in blood samples from cardiac surgery patients.

Henrik StoltCaroline Shams HakimiSukhi SinghAnders Jeppsson Martin Karlsson

Published in: Acta anaesthesiologica Scandinavica (2021)

At the selected dose, FibCLOT was more effective than Fibryga and RiaSTAP in restoring clot strength in postoperative blood samples from cardiac surgery patients. These results may have implications for the choice of fibrinogen concentrate and dosing.

Keyphrases

cardiac surgery
acute kidney injury
end stage renal disease
newly diagnosed
ejection fraction
chronic kidney disease
patients undergoing
prognostic factors
peritoneal dialysis
patient reported outcomes